Clonal Hematopoiesis clinical trials

Explore recruiting clonal hematopoiesis clinical trials.

Recruiting clonal hematopoiesis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Clonal Hematopoiesis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Study to Learn How Different Amounts of the Study Medicine Called PF-07940369 are Tolerated and Act in the Body in Healthy Adults.

Belgium

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Study to Learn How Different Amounts of the Study Medicine Called PF-07940369 are Tolerated and Act in the Body in Healthy Adults

Belgium

Human Pharmacology (Phase I)- Other EU CTIS Study details

Randomized, controlled, double-blind trial to investigate the effect of colchicin on the endothelial function in patients with CHIP mutations and chronic heart failure with reduced left ventricular function (CHIP-HF)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Randomized Interval Assessment trial of Lu177-Dotatate every 8 versus every 16 weeks in slowly progressive G1-2 advanced midgut neuroendocrine tumors (NETs) to Lower TOxicity.

Spain, France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A randomized, placebo-controlled, parallel-group, investigator- and participant-blinded Phase 2a study to investigate the efficacy, safety, and tolerability of DFV890 and MAS825 for inflammatory marker reduction in an adult population with coronary heart disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Clonal Hematopoiesis trials by city

Clonal Hematopoiesis in Toronto Clonal Hematopoiesis in Vancouver Clonal Hematopoiesis in Montreal Clonal Hematopoiesis in Calgary Clonal Hematopoiesis in Edmonton Clonal Hematopoiesis in Ottawa Clonal Hematopoiesis in Winnipeg Clonal Hematopoiesis in Quebec City Clonal Hematopoiesis in Hamilton Clonal Hematopoiesis in Kitchener Clonal Hematopoiesis in London Clonal Hematopoiesis in Halifax Clonal Hematopoiesis in New York Clonal Hematopoiesis in Los Angeles Clonal Hematopoiesis in Chicago Clonal Hematopoiesis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease